CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Probiotic E. coli (Symbioflor®2) treatment mediates antimicrobial β-defensin (hBD-2) synthesis and fecal excretion in humans
DOI 10.1055/s-0028-1089566
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Schlee, K Fellermann, K Zimmermann, H Huber, EF Stange, J Wehkamp
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Antimicrobial defensins play an important role in host defense and seem to be a critical factor in the pathogenesis of Crohns disease. Besides direct defense at mucosal surfaces, it has been shown that defensins also regulate the composition of luminal bacteria. Probiotic bacteria such as E. coli Nissle 1917 as well as Lactobacilli stimulate the intestinal innate defense by specifically inducing antimicrobial…
Zitieren
Zitierempfehlung
M Schlee, K Fellermann, K Zimmermann, H Huber, EF Stange, J Wehkamp (2008) Probiotic E. coli (Symbioflor®2) treatment mediates antimicrobial β-defensin (hBD-2) synthesis and fecal excretion in humans. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089566
Mit CareLit weiterarbeiten